Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Affiliation country
Publication year range
1.
Zhongguo Dang Dai Er Ke Za Zhi ; 26(4): 420-424, 2024 Apr 15.
Article in Zh | MEDLINE | ID: mdl-38660908

ABSTRACT

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder. With the emergence of disease-modifying therapies, the prognosis of SMA has significantly improved, drawing increased attention to the importance of home rehabilitation and nursing management. Long-term, standardized home rehabilitation and nursing can delay the progression of SMA, enhance the psychological well-being, and improve the quality of life of both patients and caregivers. This article provides an overview of the goals of home rehabilitation, basic functional training methods, respiratory management, and nutritional management for SMA patients, as well as psychological health issues, emphasizing the significance of obtaining appropriate home rehabilitation and support during the care process.


Subject(s)
Muscular Atrophy, Spinal , Humans , Muscular Atrophy, Spinal/rehabilitation , Muscular Atrophy, Spinal/therapy , Home Care Services , Quality of Life
2.
CNS Neurosci Ther ; 30(7): e14876, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39049731

ABSTRACT

AIM: This study explores the efficacy of electroacupuncture (EA) in treating cerebral palsy (CP) in Sprague-Dawley (SD) pups, specifically CP animal models, and its molecular mechanisms. METHODS: Gait analysis and Y-maze were used to detect the improvement of motor ability and cognitive function of CP rats after EA treatment. Transcription sequencing was used to determine the key pathway for EA to improve the symptoms of CP. PPAR agonists were used to verify the causal relationship between the pathway and the improvement of CP phenotype. RESULTS: The motor ability and cognitive function of CP pups were improved after EA treatment. The results of transcriptome sequencing suggest that the improvement of CP phenotype may be caused by the activation of PPAR pathway. PPAR pathway is widely activated in the epithelium of CP pups treated with EA, which is verified by qPCR. Rosiglitazone (Ros), a PPAR agonist, can improve CP phenotype while activating PPAR pathway, which proves the causal relationship between PPAR pathway activation and CP phenotype improvement. CONCLUSION: Our study demonstrated behavioral improvements and enhanced cognitive functions in CP models after EA treatment by activating PPAR pathway, suggesting new perspectives for CP rehabilitation, and providing theoretical support for acupuncture treatment of CP.


Subject(s)
Cerebral Palsy , Electroacupuncture , Peroxisome Proliferator-Activated Receptors , Phenotype , Rats, Sprague-Dawley , Electroacupuncture/methods , Cerebral Palsy/therapy , Cerebral Palsy/metabolism , Animals , Rats , Peroxisome Proliferator-Activated Receptors/agonists , Peroxisome Proliferator-Activated Receptors/metabolism , Peroxisome Proliferator-Activated Receptors/genetics , Signal Transduction/physiology , Signal Transduction/drug effects , Male , Female , Maze Learning/physiology , Maze Learning/drug effects , Disease Models, Animal , Rosiglitazone/pharmacology , Animals, Newborn
SELECTION OF CITATIONS
SEARCH DETAIL